Andrew Katims

Disclosure information not submitted.

Presentation(s):

• PD09-07: Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in node positive (N+) muscle invasive bladder cancer (MIBC) patients (pts) undergoing neoadjuvant chemotherapy (NAC)

  Friday, April 28, 2023
  2:00 PM – 2:10 PM CST